NasdaqCM - Delayed Quote USD

Soleno Therapeutics, Inc. (SLNO)

75.01
-0.06
(-0.08%)
At close: May 16 at 4:00:00 PM EDT
74.00
-1.01
(-1.35%)
After hours: May 16 at 5:56:40 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
204,131
184,429
38,670
25,109
32,259
Operating Income
-204,131
-184,429
-38,670
-25,109
-32,259
Net Non Operating Interest Income Expense
11,714
11,821
2,578
300
110
Other Income Expense
-5,808
-3,242
-2,896
742
1,239
Pretax Income
-198,225
-175,850
-38,988
-24,067
-30,910
Net Income Common Stockholders
-198,225
-175,850
-38,988
-24,067
-30,910
Diluted NI Available to Com Stockholders
-198,225
-175,850
-38,988
-24,067
-30,910
Basic EPS
-4.74
--
-2.36
-2.87
-5.81
Diluted EPS
-4.74
--
-2.36
-2.87
-5.81
Basic Average Shares
42,668.53
--
16,492.13
8,397.09
5,318.02
Diluted Average Shares
42,668.53
--
16,492.13
8,397.09
5,318.02
Total Operating Income as Reported
-209,939
-187,671
-41,384
-24,397
-31,528
Total Expenses
204,131
184,429
38,670
25,109
32,259
Net Income from Continuing & Discontinued Operation
-198,225
-175,850
-38,988
-24,067
-30,910
Normalized Income
-192,417
-172,608
-36,092
-24,809
-32,149
Interest Income
13,306
12,052
2,578
300
110
Interest Expense
1,592
231
0
0
--
Net Interest Income
11,714
11,821
2,578
300
110
EBIT
-196,633
-175,619
-38,988
-24,067
-32,259
EBITDA
-194,632
-173,632
-37,030
-22,103
-30,296
Reconciled Depreciation
2,001
1,987
1,958
1,964
1,963
Net Income from Continuing Operation Net Minority Interest
-198,225
-175,850
-38,988
-24,067
-30,910
Total Unusual Items Excluding Goodwill
-5,808
-3,242
-2,896
742
1,239
Total Unusual Items
-5,808
-3,242
-2,896
742
1,239
Normalized EBITDA
-188,824
-170,390
-34,134
-22,845
-31,535
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/13/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AKRO Akero Therapeutics, Inc.
38.87
-2.73%
 
RYTM Rhythm Pharmaceuticals, Inc.
59.93
-0.42%
 
VRNA Verona Pharma plc
71.31
+2.56%
 
CRNX Crinetics Pharmaceuticals, Inc.
31.24
+0.10%
 
CYTK Cytokinetics, Incorporated
31.00
+3.89%
 
MLTX MoonLake Immunotherapeutics
37.62
-0.11%
 
SRRK Scholar Rock Holding Corporation
30.55
-0.91%
 
ETNB 89bio, Inc.
7.78
+1.77%
 
PTCT PTC Therapeutics, Inc.
46.01
+1.54%
 
TVTX Travere Therapeutics, Inc.
16.80
-20.57%